Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL577735 | 0.84 | LMNA (0.42) | TSHRLMNAHCAR2 | |
| SCHEMBL7245151 | 0.75 | ALDH1A1 (0.41) | TSHRHCAR2 | |
| SCHEMBL7250555 | 0.74 | FAAH (0.36) | TSHRLMNAHCAR2 | |
| Tert-Butyl Hydroperoxide SCHEMBL27806184 | 0.74 | LMNA (0.35) | TSHRLMNAHCAR2 | |
| SCHEMBL13133071 | 0.73 | TSHR (0.46) | TSHRLMNAHCAR2 | |
| SCHEMBL10011696 | 0.73 | CA1 (0.37) | TSHRLMNAHCAR2 | |
| SCHEMBL452059 | 0.72 | ALDH1A1 (0.52) | TSHRLMNAHCAR2 | |
| SCHEMBL10087932 | 0.71 | LMNA (0.52) | TSHRLMNAHCAR2 | |
| SCHEMBL15986332 | 0.71 | HCAR2 (0.39) | TSHRLMNAHCAR2 | |
| SCHEMBL8861415 | 0.70 | HSD17B10 (0.38) | TSHRLMNAHCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030069204-A1 | Strain of streptomyces | SANKYO COMPANY LIMITED (JP) | 2003-04-10 | — | — | US | disclosed |
| EP-0497978-A1 | CEPHALOSPORIN COMPOUNDS AND PRODUCTION THEREOF | Kyoto Pharmaceutical Industries, Ltd. (JP) | 1992-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069204-A1 | Strain of streptomyces | O60361, CYP8B1, MRPS34 | TSHR 3757/4885LMNA 3952/4885HCAR2 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.